To explore changes in the UFM1 pathway, we first examined published single nuclei transcriptomic data [35] and discovered that most genes related to the UFMylation pathway were dysregulated in excitatory neurons of AD patients. This evidence concerns the gene UFM1 and Alzheimer disease.